186 related articles for article (PubMed ID: 36719469)
1. m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.
Wang K; Wang G; Li G; Zhang W; Wang Y; Lin X; Han C; Chen H; Shi L; Reheman A; Li J; Li Z; Yang X
Apoptosis; 2023 Apr; 28(3-4):627-638. PubMed ID: 36719469
[TBL] [Abstract][Full Text] [Related]
2.
Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
[TBL] [Abstract][Full Text] [Related]
3. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
Ma H; Shen L; Yang H; Gong H; Du X; Li J
IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
[TBL] [Abstract][Full Text] [Related]
4. RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m
Ye J; Chen X; Jiang X; Dong Z; Hu S; Xiao M
J Clin Lab Anal; 2022 Jul; 36(7):e24514. PubMed ID: 35689537
[TBL] [Abstract][Full Text] [Related]
5. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
[TBL] [Abstract][Full Text] [Related]
6. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
7. WTAP Mediates NUPR1 Regulation of LCN2 Through m
Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
[TBL] [Abstract][Full Text] [Related]
8. METTL4 mediated-N6-methyladenosine promotes acute lung injury by activating ferroptosis in alveolar epithelial cells.
Sang A; Zhang J; Zhang M; Xu D; Xuan R; Wang S; Song X; Li X
Free Radic Biol Med; 2024 Mar; 213():90-101. PubMed ID: 38224757
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis.
Shen H; Xie K; Tian Y; Wang X
Apoptosis; 2023 Apr; 28(3-4):514-524. PubMed ID: 36645573
[TBL] [Abstract][Full Text] [Related]
10. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.
Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C
FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.
Cao P; Zhang W; Qiu J; Tang Z; Xue X; Feng T
Cancer Res Treat; 2024 Jan; 56(1):259-271. PubMed ID: 37591781
[TBL] [Abstract][Full Text] [Related]
12. m6A methyltransferase WTAP regulates myocardial ischemia reperfusion injury through YTHDF1/FOXO3a signaling.
Wang H; Fu L; Li Y; Wei L; Gu X; Li H; Li J; Wen S
Apoptosis; 2023 Jun; 28(5-6):830-839. PubMed ID: 36894806
[TBL] [Abstract][Full Text] [Related]
13. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
14. WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.
Chen S; Xia H; Sheng L
Dig Liver Dis; 2023 Jul; 55(7):967-981. PubMed ID: 36586770
[TBL] [Abstract][Full Text] [Related]
15. N
Yu H; Zhao K; Zeng H; Li Z; Chen K; Zhang Z; Li E; Wu Z
Biomed Pharmacother; 2021 Jan; 133():111075. PubMed ID: 33378974
[TBL] [Abstract][Full Text] [Related]
16. Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.
Fan Y; Li X; Sun H; Gao Z; Zhu Z; Yuan K
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139062
[TBL] [Abstract][Full Text] [Related]
17. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
18. HIF-1
Lyu Y; Zhang Y; Wang Y; Luo Y; Ding H; Li P; Ni G
J Immunol Res; 2022; 2022():6130806. PubMed ID: 35733918
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine (m6A) RNA methylation mediated by methyltransferase complex subunit WTAP regulates amelogenesis.
Xie F; Zhu X; Liu X; Chen H; Wang J
J Biol Chem; 2022 Dec; 298(12):102715. PubMed ID: 36403857
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of fat mass and obesity alleviates the ferroptosis in Parkinson's disease through m6A-NRF2-dependent manner.
Pang P; Zhang S; Fan X; Zhang S
Cell Biol Int; 2024 Apr; 48(4):431-439. PubMed ID: 38180302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
